Announcements Trials
Browse Landscape

Phase

Phase NA 89Phase 1 15Phase 2 14Phase 1/2 6Phase EARLY_PHASE1 4Phase 3 1

Status

Withdrawn 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Urinary Bladder Neoplasms 1Thoracic Spine Neoplasm 1Pancreatic Neoplasms 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 61Cyclophosphamide 57pembrolizumab 39fludarabine 38Radiotherapy 30Nivolumab 30Biopsy 27Metformin 23Fluorodeoxyglucose F18 22Bevacizumab 22Specimen Handling 21Temozolomide 18Cisplatin 18Radiosurgery 17Carboplatin 16Fluorouracil 15Paclitaxel 14Dexamethasone 14Radiation 13Gemcitabine 13Etoposide 13Rituximab 12Positron Emission Tomography Computed Tomography 12Letrozole 12Irinotecan 12gallium 68 PSMA-11 11durvalumab 11atezolizumab 11X-Rays 11Surgical Procedures, Operative 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Interventional × Magnetic Resonance Imaging × Clear all
NCT04369560 2025-12-17

Virtual Histology of the Bladder Wall for Bladder Cancer Staging

University of Pittsburgh

Phase EARLY_PHASE1 Recruiting
42 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02683824 2023-09-21

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

Stanford University

Phase EARLY_PHASE1 Completed
21 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04563806 2022-07-11

Safety of MRI Compatible Hardware for MRI-based Image Guidance During Spine Surgery

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
16 enrolled

Thoracic Spine Neoplasm

NCT03193463 2019-03-01

Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Withdrawn
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡